Issue 4, 2024

A protocol for directly accessing geminal C-4 diarylated pyrazol-5(4H)-ones via tandem C–H aryne insertion and their inceptive neurobiological evaluation

Abstract

Geminal C-4 diarylation of substituted pyrazol-5(4H)-ones with in situ generated arynes as the aryl source has been achieved in a one-flask operation. All the newly accessed C4-gem-diarylated pyrazolone entities were found to be non-cytotoxic with varying AChE enzyme inhibitory activities and BBB permeability attributes that augur well for further advancement towards CNS therapeutics for untreatable disorders.

Graphical abstract: A protocol for directly accessing geminal C-4 diarylated pyrazol-5(4H)-ones via tandem C–H aryne insertion and their inceptive neurobiological evaluation

Supplementary files

Article information

Article type
Communication
Submitted
28 Nov 2023
Accepted
19 Dec 2023
First published
19 Dec 2023

Org. Biomol. Chem., 2024,22, 714-719

A protocol for directly accessing geminal C-4 diarylated pyrazol-5(4H)-ones via tandem C–H aryne insertion and their inceptive neurobiological evaluation

K. A. Sudarshana, M. J. Sarma, M. Radhakrishnan, S. Chakravarty, P. Srihari and G. Mehta, Org. Biomol. Chem., 2024, 22, 714 DOI: 10.1039/D3OB01932B

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements